{rfName}
SB

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Boladeras, AAuthorStefanovic, MAuthorAlvarez, AAuthorSlocker, AAuthorGutierrez, CAuthorPicon, CAuthorGuedea, FAuthor

Share

Publications
>
Other

SBRT prostate cancer boost of 9 Gy, prospective phase II trial

Publicated to:Radiotherapy And Oncology. 161 S1091-S1092 - 2021-08-01 161(), DOI:

Authors: Gonzalez, FF; Pont, A; De Blas, R; Boladeras, A; Garin, O; Expósito, NG; Stefanovic, M; Marqueta, MG; Juarez, M; Olivas, M; Armijos, L; Becerra, MA; Alvarez, A; Slocker, A; Ventura, M; Castells, M; Merino, E; Suarez, F; Gutiérrez, C; Delgado, J; Zardoya, E; Najjari, D; Picon, C; Ferrer, M; Guedea, F

Affiliations

Abstract

Keywords

Astronomia / físicaCiências biológicas iCiências biológicas iiEngenharias iiEngenharias ivGeneral medicineHematologyInterdisciplinarMedicina iMedicina iiOdontologíaOncologyRadiology, nuclear medicine & medical imagingRadiology, nuclear medicine and imagingSaúde coletiva

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Radiotherapy And Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 22/136, thus managing to position itself as a Q1 (Primer Cuartil), in the category Radiology, Nuclear Medicine & Medical Imaging.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Gonzalez, FF) and Last Author (Guedea Edo, Ferran).